Relief Therapeutics Holding AG (RLFTF)

[Clarnold]

Just reviewing timeline. https://www.tradingview.com/symbols/OTC-RLFTF/

If you look at the news timeline from the page above, patients were first enrolled back on June 2nd. Then expanded the trial and got fast track designation on June 24th. July 17th, they sign a deal with GEM. Then July 26th get expanded access protocol for the study. Then August 2nd, Reuters Tel Aviv broke the story patients had recovered quickly after 3 days. Why are we seeing the stock price shoot up now?

March 14 - Study is first posted. https://clinicaltrials.gov/ct2/show/NCT04311697?term=Aviptadil&draw=1&rank=1

May 15 - IV RLF-100 study start date w/ 144 patients. Looks like in Houston, Kentucky, California and Florida. (see previous link)

June 2 - Patients enrolled in study for RLF-100 (see previous link)

June 11 - Houston announces 6 patients have recovered and that the study will be expanded. https://www.globenewswire.com/news-release/2020/06/11/2046611/0/en/Relief-Therapeutics-and-NeuroRx-Expand-Clinical-Trial-Evaluating-RLF-100-in-Critically-Ill-COVID-19-Patients-with-Respiratory-Failure-to-Houston-Methodist-Hospital.html

June 24 - FDA Fast track designation. https://www.globenewswire.com/news-release/2020/06/24/2052448/0/en/NeuroRx-and-Relief-Therapeutics-Announce-Fast-Track-Designation-Granted-by-the-FDA-to-RLF-100-Aviptadil-for-the-Treatment-of-Respiratory-Distress-in-COVID-19.html

July 17 - inked a deal with GEM for 58 million shares to close at END OF JULY. https://relieftherapeutics.com/relief-therapeutics-holding-sa-to-agree-share-settlement-for-an-outstanding-chf-1723300-debt-position-provided-by-gem/

July 26 - Expanded access protocol to include those that are very sick and cannot be part of the trial and pregnant women. https://www.marketwatch.com/press-release/fda-grants-expanded-access-protocol-to-rlf-100-aviptadil-for-respiratory-failure-in-covid-19-currently-in-development-by-neurorx-and-relief-therapeutics-under-fast-track-designation-2020-07-29?mod=mw_quote_news&tesla=y

August 2 - From Tel Aviv, NeuroRX and Relief announce that patients have recovered quickly. https://www.jpost.com/international/relief-neurorx-say-rlf-100-emergency-treatment-helps-covid-19-patients-637278


I'm fully on board, I'm just trying to go back and fact check some of this or make sure this makes sense to me. It seems VERY convenient that GEM's deal closed in July and then we get reports over the weekend August 1/2 that patients are quickly recovering. The price popped in June for 2 days and went back down. I know there is a lot of good news but why won't this pop and go back down again? Again it seems very convenient when we've had good news throughout all of June and July and now that GEM is involved we have a huge breakout in price.

I'm still on board I'm just trying to be skeptical and look at the big picture of what is going on.

Thoughts?

-